ADDED
(Exact name of registrant as specified in its charter) ________________________________ Cayman Islands 06-1686563 (State or other jurisdiction of incorporation or organization) (I.R.S.
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
The number of the Registrant s Ordinary Shares outstanding as of February 23, 2026 was 27,556,767 .
Market for Registrant s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities 103 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 105 Item 7A .
Forward-looking statements generally relate to future events or our future financial or operating performance.
The words believe, may, will, potentially, estimate, continue, anticipate, predict, target, intend, could, would, should, project, plan, expect, and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
You should read these risk factors and the other cautionary statements made in this report as being applicable to all related forward-looking statements wherever they appear in this report.
The risk factors are not exhaustive and other sections of this report may include additional factors which could adversely impact our business and financial performance.
REMOVED
(Exact name of Registrant as specified in its charter) Delaware 06-1686563 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) P.O.
See definitions of large accelerated filer, accelerated filer , smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
At February 7, 2025, 64,513,862 shares of GlycoMimetics, Inc.
s Common Stock, $0.001 par value per share, were outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations, but are also contained elsewhere in this Annual Report.
In some cases, you can identify forward-looking statements by the words may, might, will, could, would, should, expect, intend, plan, objective, anticipate, believe, estimate, predict, project, potential, continue and ongoing, or the negative of these terms, or other comparable terminology intended to identify statements about the future.
These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements.
Although we believe that we have a reasonable basis for each forward-looking statement contained in this Annual Report, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain.
Forward-looking statements include statements about: our plans to consummate the proposed merger, or the Merger, between us and Crescent Biopharma, Inc.
Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material.